Literature DB >> 9811806

Bone homeostasis.

G A Rodan1.   

Abstract

Mesh：

Year:  1998        PMID： 9811806      PMCID： PMC33917          DOI： 10.1073/pnas.95.23.13361

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  11 in total

1.  Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo.

Authors:  T M Skerry; L Bitensky; J Chayen; L E Lanyon
Journal:  J Bone Miner Res       Date:  1989-10       Impact factor: 6.741

Review 2.  Bone mass homeostasis and bisphosphonate action.

Authors:  G A Rodan
Journal:  Bone       Date:  1997-01       Impact factor: 4.398

3.  Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Authors:  D L Lacey; E Timms; H L Tan; M J Kelley; C R Dunstan; T Burgess; R Elliott; A Colombero; G Elliott; S Scully; H Hsu; J Sullivan; N Hawkins; E Davy; C Capparelli; A Eli; Y X Qian; S Kaufman; I Sarosi; V Shalhoub; G Senaldi; J Guo; J Delaney; W J Boyle
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

4.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.

Authors:  J Pfeilschifter; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Role of osteoblasts in hormonal control of bone resorption--a hypothesis.

Authors:  G A Rodan; T J Martin
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

6.  The cellular basis of bone resorption.

Authors:  T J Chambers
Journal:  Clin Orthop Relat Res       Date:  1980-09       Impact factor: 4.176

Review 7.  Bone microdamage and skeletal fragility in osteoporotic and stress fractures.

Authors:  D B Burr; M R Forwood; D P Fyhrie; R B Martin; M B Schaffler; C H Turner
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

8.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose.

Authors:  P V Hauschka; A E Mavrakos; M D Iafrati; S E Doleman; M Klagsbrun
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

10.  Dissociation between bone resorption and bone formation in osteopenic transgenic mice.

Authors:  D A Corral; M Amling; M Priemel; E Loyer; S Fuchs; P Ducy; R Baron; G Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205
View more
  37 in total

1.  Thy1 is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice.

Authors:  Ananta Paine; Collynn F Woeller; Hengwei Zhang; Maria de la Luz Garcia-Hernandez; Nelson Huertas; Lianping Xing; Richard P Phipps; Christopher T Ritchlin
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

Review 2.  Minireview: nuclear receptor regulation of osteoclast and bone remodeling.

Authors:  Zixue Jin; Xiaoxiao Li; Yihong Wan
Journal:  Mol Endocrinol       Date:  2014-12-30

3.  Medial tibial subchondral bone is the key target for extracorporeal shockwave therapy in early osteoarthritis of the knee.

Authors:  Ching-Jen Wang; Jai-Hong Cheng; Chien-Yiu Huang; Shan-Ling Hsu; Fan-Yen Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

4.  Controlled Release of Vanadium from a Composite Scaffold Stimulates Mesenchymal Stem Cell Osteochondrogenesis.

Authors:  S D Schussler; K Uske; P Marwah; F W Kemp; J D Bogden; S S Lin; Treena Livingston Arinzeh
Journal:  AAPS J       Date:  2017-03-22       Impact factor: 4.009

5.  Trabecular architecture of the great ape and human femoral head.

Authors:  Leoni Georgiou; Tracy L Kivell; Dieter H Pahr; Laura T Buck; Matthew M Skinner
Journal:  J Anat       Date:  2019-02-21       Impact factor: 2.610

6.  Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.

Authors:  Changcheng Zhou; Mahfoud Assem; Jessica C Tay; Paul B Watkins; Bruce Blumberg; Erin G Schuetz; Kenneth E Thummel
Journal:  J Clin Invest       Date:  2006-05-11       Impact factor: 14.808

7.  Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.

Authors:  Nanda K Thudi; Chelsea K Martin; Murali V P Nadella; Soledad A Fernandez; Jillian L Werbeck; Joseph J Pinzone; Thomas J Rosol
Journal:  Prostate       Date:  2008-07-01       Impact factor: 4.104

Review 8.  Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.

Authors:  Hyun-Ju Cho; Hyun-Jai Cho; Hyo-Soo Kim
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

9.  Exosomes: roles and therapeutic potential in osteoarthritis.

Authors:  Zhenhong Ni; Siru Zhou; Song Li; Liang Kuang; Hangang Chen; Xiaoqing Luo; Junjie Ouyang; Mei He; Xiaolan Du; Lin Chen
Journal:  Bone Res       Date:  2020-06-19       Impact factor: 13.567

10.  Effect of Oral Submucous Fibrosis on Jaw Dimensions.

Authors:  Aarati Panchbhai
Journal:  Turk J Orthod       Date:  2019-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.